Research output per year
Research output per year
Fingerprint
Dive into the research topics where Marilia Barreca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas
Montalbano, A., Spano', V., Barraja, P., Raimondi, M. V., Bivacqua, R., Barreca, M., Hamel, E., Bertoni, F., Rocca, R., Tarantelli, C., Maruca, A., Prota, A. E., Cascione, L., Abel, A-C., Rinaldi, A., Bai, R., Gaudio, E., Alcaro, S. & Steinmetz, M. O., 2022, In: European Journal of Medicinal Chemistry. 243, p. 1-25 25 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
GPCR Inhibition in Treating Lymphoma
Montalbano, A., Giuffrida, S., Raimondi, M. V., Barreca, M., Bivacqua, R., Barraja, P., Spano', V., Bertoni, F. & Cavalli, A., 2022, In: ACS Medicinal Chemistry Letters. p. 1-7 7 p.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus) -
Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells
Montalbano, A., Spano', V., Ingarra, A. M., Barreca, M., Barraja, P., Raimondi, M. V., Gandin, V., Menilli, L., De Franco, M. & Miolo, G., 2022, In: European Journal of Medicinal Chemistry. 237, p. 1-16 16 p.Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus) -
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line
Montalbano, A., Barreca, M., Notarbartolo Di Villarosa, M., Barraja, P., Raimondi, M. V., Labbozzetta, M., Spano', V. & Poma, P., 2022, In: Drug Development Research. p. 1-11 11 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Synthesis of 2H-Imidazo[2′,1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations
Barreca, M., Spano', V., Montalbano, A., Raimondi, M. V., Barraja, P., Bortolozzi, R., Rocca, R., Maruca, A., Ronca, R., Alcaro, S. & Viola, G., 2022, In: European Journal of Medicinal Chemistry. 235, p. 1-21 21 p.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus)
Projects
- 1 Finished
-
Selective mGlu3 metabotropic glutamate receptor ligands as new potential therapeutic agents in experimental models of parkinsonism.
Spano', V., Belluardo, N., Carbone, A., Scaduto, P., Barraja, P., Barreca, M., Montalbano, A. & Mudo', G.
8/29/19 → 8/29/22
Project: Research project